Serum T
3 level in various thyroid diseases was determined in unextracted serum with the Dainabot kit for T
3 RIA. The serum T
3 level in 33 normal subjects was 0.8-1.6ng/ml. It was 5.7±3.5ng/ml (mean± S.D.) in 36 hyperthyroid patients, and undetectable to 0.8 ng/ml in 21 hypothyroid patients.
Generally the serum T
4 and serum T
3 decreased in parallel after radioiodine therapy for hyperthyroidism. However, in some cases the serum T
3 level remained high in spite of normalized serum T
4 after radioiodine therapy. This state indicated “T
3-toxicosis”, and hyperthyroidism was apt to recur. When thyroid function was observed for 2 years following radioiodine treatment, the ratio of serum T
3 (T
3 level before treatment/T
3 level after treatment) decreased more significantly as compared with the ratio of serum T
4 in euthyroid cases. Serum T
3 provides a more sensitive index of thyroid function than serum T
4 in euthyroid states after radioiodine or anti-thyroid drug therapy.
The present data indicate that the serum T
3 level and the T
4/T
3 ratio are valuable aids in the estimation of prognosis of hyperthyroid patients after various treatments.
View full abstract